What this test measures
N-acetyl-β-D-glucosaminidase (NAG) is a lysosomal enzyme abundant in proximal renal tubular cells. It is too large to be filtered at the glomerulus, so its appearance in urine indicates injury or turnover of tubular cells. NAG rises earlier than serum creatinine in nephrotoxic injury and earlier than microalbuminuria in diabetic kidney disease, but it is not yet a routine clinical test in most Indian labs.
It is typically expressed as units/g creatinine to correct for hydration. NAG is part of a wider family of tubular injury markers (KIM-1, NGAL, β2-microglobulin, α1-microglobulin) — none has yet replaced creatinine and microalbumin in standard practice, but they have research and specialised clinical applications.
Why it matters
In India, NAG is mostly a research test or used in specialised nephrology practice. It can detect early tubular injury from nephrotoxic drugs (aminoglycoside antibiotics, vancomycin, cisplatin, contrast media, NSAIDs, heavy metals — lead, cadmium, mercury), in early diabetic nephropathy (before microalbuminuria), in interstitial nephritis, and in chronic occupational toxin exposure.
It has not displaced standard tests (creatinine, eGFR, microalbumin) because of variable assays, lack of standardisation, and limited evidence on outcomes. For most Indian patients, microalbumin / UACR plus eGFR remain the right first tests for kidney disease.
How to prepare
A first morning spot urine sample is preferred. No fasting required. Avoid vigorous exercise in the 24 hours before. Do not collect during menstruation or active urinary tract infection — both alter the value. Mention nephrotoxic drugs (aminoglycosides, vancomycin, NSAIDs, recent contrast scan).
Markers & reference ranges
Reference ranges below are typical adult values. Your lab's reported range may differ slightly based on the assay platform and patient demographics — always read your report against the range printed on it.
| Marker | Normal range | If low | If high |
|---|---|---|---|
| Urinary NAG (U/g creatinine)[1][2] | < 11 U/g creatinine (method-dependent — confirm with lab) | Low / normal NAG is reassuring for tubular health but does not exclude glomerular disease — interpret alongside eGFR and microalbumin. | High NAG suggests proximal tubular injury. Common causes — aminoglycoside / vancomycin / cisplatin / contrast-induced injury, NSAID nephrotoxicity, early diabetic nephropathy (before microalbuminuria), acute interstitial nephritis, heavy metal exposure (lead, cadmium, mercury), early reflux nephropathy. NAG rises and falls quickly — useful for serial monitoring during nephrotoxic therapy. |
Tubular injury markers
| Marker | Strength | Limitations |
|---|---|---|
| Serum Creatinine / eGFR | Standard, available everywhere | Late to rise; reflects glomerular filtration, not tubular injury |
| Urine Microalbumin / UACR | Standard for glomerular damage; recommended in DM / HTN | Misses tubular injury |
| NAG (urinary) | Early tubular injury marker | Limited availability; not standardised across labs |
| KIM-1 (urinary) | Specific tubular injury marker; research and selected clinical use | Not widely available in India |
| NGAL (urinary / serum) | Early acute kidney injury marker, especially in ICU | Cost, variability |
Frequently asked questions
When is NAG useful?
Mainly in specialised nephrology — monitoring nephrotoxic drug therapy (aminoglycosides, vancomycin, cisplatin), early diabetic kidney disease before microalbuminuria, heavy metal exposure surveillance, and research. For routine kidney screening, microalbumin / UACR + eGFR are preferred.
Do I need to fast?
No. A first morning spot urine is preferred. Avoid testing during a UTI, menstruation, or after vigorous exercise.
Is NAG more sensitive than microalbumin for diabetic kidney disease?
NAG can rise before microalbuminuria but evidence is limited. Microalbumin (UACR) is still the recommended screening test because it has clear treatment thresholds and outcome data.
Can a UTI raise NAG?
Yes — any active urinary tract inflammation can falsely raise NAG. Treat the UTI first and re-test after resolution.
Will my doctor act on a raised NAG?
Usually they will re-check and combine it with clinical context — drug history, eGFR, microalbumin, urine sediment. An isolated raised NAG without other findings does not by itself prove a clinically important problem.
Is NAG widely available in India?
It is available in some larger reference labs and academic centres but is not a routine test. Confirm availability with your lab and clinical relevance with your nephrologist.
Related Other / Biochemistry tests
Tests commonly ordered alongside N ACETYL BETA D GLUCOSAMINIDASE, or that help interpret an unexpected result.
Sources & references
- KDIGO 2024 CKD Clinical Practice Guideline · accessed 2026-05-30T00:00:00.000Z
- Mayo Clinic Laboratories — N-Acetyl-Beta-D-Glucosaminidase · accessed 2026-05-30T00:00:00.000Z
- NCBI Review — Urinary NAG as a Biomarker of Tubular Injury · accessed 2026-05-30T00:00:00.000Z
Book with Zelnoo
Get your N ACETYL BETA D GLUCOSAMINIDASE test done at home — transparent prices, NABL-accredited labs.
Zelnoo lets you compare diagnostic test prices across NABL-accredited labs in Mumbai & Thane, book a free home phlebotomist visit, and receive digital reports in 24–48 hours into a consent-first report vault. No subscriptions, no membership fees — pay only for the test you book.
Book N ACETYL BETA D GLUCOSAMINIDASE now